Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nephron

Showing results (421-430 of 9,343) with videos related to

Pageof 935
Sort By:
Nephron|January 1, 1995
Gallstone disease in dialysis patientsU Gladziwa
Nephron|January 1, 1995
Eicosanoids and renal allograft rejectionE N Wardle
Nephron|January 1, 1995
Oral activated charcoal in patients with uremic pruritusS Giovannetti, G Barsotti, A Cupisti, et al.
Nephron|January 1, 1995
No acute change of serum erythropoietin in response to hypocalcemia or antihypertensive agents in uremic patientsP Ureña, L Bererhi, S Houhou, et al.
Nephron|January 1, 1995
Decreased uroporphyrinogen decarboxylase activity in patients with end-stage renal disease undergoing hemodialysisR Mamet, U Gafter, A Korzets, et al.
Nephron|January 1, 1995
Potassium depletion potentiates amphotericin-B-induced toxicity to renal tubulesJ F Bernardo, S Murakami, R A Branch, et al.
Nephron|January 1, 1995
Bowel perforation associated with continuous ambulatory peritoneal dialysisL C Thibodeaux
Nephron|January 1, 1995
Erythrocyte aggregation before and after haemodialysisL Houbouyan, J F Stoltz, A Beauchet, et al.
Nephron|January 1, 1995
Dysfunction of myoplasmic Ca2+ regulation in skeletal muscle from predialytic uremic patientsJ R Lopez, B Rojas, V Parthe, et al.
Nephron|January 1, 1984
A new antithrombotic agent in the treatment of acute renal failure due to hemolytic-uremic syndrome and thrombotic thrombocytopenic purpuraV Bonomini, A Vangelista, G Frascà
Pageof 935

Showing results (421-430 of 9,343) with videos related to

Sort By:
Pageof 935
Nephron|January 1, 1995
Gallstone disease in dialysis patientsU Gladziwa
Nephron|January 1, 1995
Eicosanoids and renal allograft rejectionE N Wardle
Nephron|January 1, 1995
Oral activated charcoal in patients with uremic pruritusS Giovannetti, G Barsotti, A Cupisti, et al.
Nephron|January 1, 1995
No acute change of serum erythropoietin in response to hypocalcemia or antihypertensive agents in uremic patientsP Ureña, L Bererhi, S Houhou, et al.
Nephron|January 1, 1995
Decreased uroporphyrinogen decarboxylase activity in patients with end-stage renal disease undergoing hemodialysisR Mamet, U Gafter, A Korzets, et al.
Nephron|January 1, 1995
Potassium depletion potentiates amphotericin-B-induced toxicity to renal tubulesJ F Bernardo, S Murakami, R A Branch, et al.
Nephron|January 1, 1995
Bowel perforation associated with continuous ambulatory peritoneal dialysisL C Thibodeaux
Nephron|January 1, 1995
Erythrocyte aggregation before and after haemodialysisL Houbouyan, J F Stoltz, A Beauchet, et al.
Nephron|January 1, 1995
Dysfunction of myoplasmic Ca2+ regulation in skeletal muscle from predialytic uremic patientsJ R Lopez, B Rojas, V Parthe, et al.
Nephron|January 1, 1984
A new antithrombotic agent in the treatment of acute renal failure due to hemolytic-uremic syndrome and thrombotic thrombocytopenic purpuraV Bonomini, A Vangelista, G Frascà
Pageof 935